Whitehawk Therapeutics, Inc. · NASDAQ:WHWK

Lennon David James received 51,021 Whitehawk Therapeutics, Inc. shares as an award (Form 4)

Traded May 14, 2026 · Filed May 18, 2026

On May 14, 2026, Lennon David James (Director, CHIEF EXECUTIVE OFFICER) received 51,021 Whitehawk Therapeutics, Inc. shares as an award at US$3.92 for US$200K, leaving 569,643 shares. Filed May 18, 2026 (Form 4).

Awarded
51,021 shares
Price
US$3.92
Value
US$200K
Holding after
569,643 shares
Trading plan
No
Role
Director, CHIEF EXECUTIVE OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 14, 2026Common StockAward51,021US$3.92569,643Direct

Source

View original at SEC

Related